Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
cbdMD
YCBD
$6.28M
| $30K | ﹤0.01% |
2,651
+1,999
| +307% | +$52.4K |
|
|
AVGR
3702
DELISTED
Avinger, Inc. Common Stock
AVGR
| $30K | ﹤0.01% |
2,731
+213
| +8% | +$1.9K |
|
|
CORR
3703
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $30K | ﹤0.01% |
26,400
-1,200
| -4% | -$1.32K |
|
|
FATH
3704
DELISTED
Fathom Digital Manufacturing Corporation
FATH
| $30K | ﹤0.01% |
3,654
+2,739
| +299% | +$24.9K |
|
|
DUO
3705
Fangdd Network Group
DUO
$24.9M
| $29K | ﹤0.01% |
138
-3
| -2% | -$636 |
|
3706
GT Biopharma
GTBP
$10.9M
| $29K | ﹤0.01% |
3,073
+760
| +33% | +$7.88K |
|
|
HITI
3707
High Tide
HITI
$205M
| $29K | ﹤0.01% |
+23,613
| New | +$30.7K |
|
3708
Immix Biopharma
IMMX
$809M
| $29K | ﹤0.01% |
+10,600
| New | +$22.2K |
|
|
TC
3709
TuanChe
TC
$61.3M
| $29K | ﹤0.01% |
194
-1
| -0.5% | -$168 |
|
|
ZTEK
3710
Zentek
ZTEK
$79.7M
| $29K | ﹤0.01% |
+18,400
| New | +$29K |
|
|
NXXT
3711
NextNRG Inc
NXXT
$46.9M
| $29K | ﹤0.01% |
4,962
+1,722
| +53% | +$10.1K |
|
|
NOGN
3712
DELISTED
Nogin, Inc. Common Stock
NOGN
| $29K | ﹤0.01% |
+22,500
| New | +$41.2K |
|
|
BHAT
3713
DELISTED
Blue Hat Interactive Entertainment Technology
BHAT
| $28K | ﹤0.01% |
5
+1
| +25% | +$4.71K |
|
3714
CN Energy Group
CNEY
$5.11M
| $28K | ﹤0.01% |
185
-149
| -45% | -$23.3K |
|
|
FRSX
3715
Foresight Autonomous Holdings
FRSX
$4.02M
| $28K | ﹤0.01% |
623
+282
| +83% | +$12.7K |
|
3716
iBio
IBIO
$73M
| $28K | ﹤0.01% |
2,305
-1,090
| -32% | -$20.6K |
|
|
PLG
3717
Platinum Group Metals
PLG
$196M
| $28K | ﹤0.01% |
19,386
+7,686
| +66% | +$11.7K |
|
3718
Rapid Micro Biosystems
RPID
$84.8M
| $28K | ﹤0.01% |
27,766
-12,934
| -32% | -$13.1K |
|
|
JXG
3719
JX Luxventure
JXG
$85.6M
| $28K | ﹤0.01% |
217
-2
| -0.9% | -$523 |
|
|
RNTX
3720
Rein Therapeutics
RNTX
$68.9M
| $28K | ﹤0.01% |
15,864
+3,200
| +25% | +$4.93K |
|
|
CYTH
3721
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
| $28K | ﹤0.01% |
+17,800
| New | +$22.7K |
|
|
ID
3722
DELISTED
PARTS iD, Inc.
ID
| $28K | ﹤0.01% |
67,600
+42,100
| +165% | +$15.9K |
|
|
ADAG
3723
Adagene
ADAG
$248M
| $27K | ﹤0.01% |
18,402
-21,239
| -54% | -$29.1K |
|
3724
Corvex Inc
MOVE
$300M
| $27K | ﹤0.01% |
+224
| New | +$26.9K |
|
3725
Satellogic
SATL
$919M
| $27K | ﹤0.01% |
13,740
-8,960
| -39% | -$18.8K |
|
Similar funds
Jim Simons's Q2 2023 Portfolio in Review
As of Q2 2023, Jim Simons held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Berkshire Hathaway Class A worth $316M.
- Jim Simons's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Jim Simons added most to Apple in Q2 2023, an estimated $856M increase.
- Jim Simons's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Jim Simons fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Jim Simons's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Jim Simons opened 541 new positions and closed 599 in Q2 2023.
- Jim Simons's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.